Acta Pharmaceutica Sinica B Volume 10, Issue 9 publishes

October 27, 2020

The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association, Acta Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences -- including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.

Featured papers in this issue are:

Deficiency of anti-inflammatory cytokine IL-4 leads to neural hyperexcitability and aggravates cerebral ischemia-reperfusion injury by authors Xiaoling Chen, Jingliang Zhang, Yan Song, Pan Yang, Yang Yang, Zhuo Huang and Kewei Wang

(https://doi.org/10.1016/j.apsb.2020.05.002). In this paper, the authors describe a previously unknown mechanism by which IL-4 deficiency causes neural hyperexcitability and enhances neuronal excitatory transmissions. Supplementing IL-4 might be beneficial for improvement of functional recovery after brain ischemia injury.

Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe(?/?) mice by authors Xiaolei Ma, Tingting Zhang, Zhigang Luo, Xiaolin Lia, Miao Lin, Rui Li, Peng Du, Xiaoyou Yu, Chen Ma Pengju Yan, Jin Su, Lulu Wanga, Yuhuan Lic and Jiandong Jiang

(https://doi.org/10.1016/j.apsb.2020.03.005). The authors investigated BT1500M, which increased gut-absorption and intra-cellular uptake of berberine, modulated AMPK and NF-kB expression, and improved dyslipidemia and inflammation induced by high fat diet. The endothelial injury and subsequent macrophage infiltration and cholesteryl ester gathering in the aortic arch were decreased, resulting in the inhibition of artery plaque build-up.

Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors by authors Liying Ma, Haojie Wang, Yinghua You, Chaoya Ma, Yuejiao Liu, Feifei Yang, Yichao Zheng and Hongmin Liu

(https://doi.org/10.1016/j.apsb.2020.02.006). The authors designed and synthesized series II compounds (14a-w) based on the flavin adenine dinucleotide (FAD) similarity strategies. Further mechanism studies showed that compound 14q is an FAD competitive LSD1 inhibitor, which inhibits cell migration and invasion by reversing epithelial to mesenchymal transition (EMT).

Other articles published in the issue include:

Review articles

Recent advances of antibody drug conjugates for clinical applications

Pengxuan Zhao, Yuebao Zhang, Wenqing Li, Christopher Jeanty et al.

https://doi.org/10.1016/j.apsb.2020.04.012

Targeting necroptosis in anticancer therapy: mechanisms and modulators

Ying Wu, Guoqiang Dong, Chunquan Sheng

https://doi.org/10.1016/j.apsb.2020.01.007

Original articles

Icariside ?, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation

Zhilei Wang, Guang Xu, Hongbo Wang, Xiaoyan Zhan et al.

https://doi.org/10.1016/j.apsb.2020.03.006

Transporters (OATs and OATPs) contribute to illustrate the mechanism of medicinal compatibility of ingredients with different properties in yuanhuzhitong prescription

Ze Wang, Haihua Shang, Yazhuo Li, Chen Zhang et al.

https://doi.org/10.1016/j.apsb.2020.05.012

First small-molecule PROTACs for G protein-coupled receptors: inducing α1A-adrenergic receptor degradation

Zhenzhen Li, Yuxing Lin, Hui Song, Xiaojun Qin et al.

https://doi.org/10.1016/j.apsb.2020.01.014

Nonclinical safety, tolerance and pharmacodynamics evaluation for meplazumab treating chloroquine-resistant Plasmodium falciparum

Kun Zhang, Yu Zhao, Zheng Zhang, Mengyao Zhang et al.

https://doi.org/10.1016/j.apsb.2020.06.011

Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics

Chongjin Zhong, Chao Jiang, Suiying Ni, Qizhi Wang et al.

https://doi.org/10.1016/j.apsb.2019.12.011

Glycoside scutellarin enhanced CD-MOF anchoring for laryngeal delivery

Kena Zhao, Tao Guo, Caifen Wang, Yong Zhou et al.

https://doi.org/10.1016/j.apsb.2020.04.015

Computed tomography and photoacoustic imaging guided photodynamic therapy against breast cancer based on mesoporous platinum with insitu oxygen generation ability

Lingyan Zhang, Mifang Li, Quan Zhou, Meng Dang et al.

https://doi.org/10.1016/j.apsb.2020.05.003

Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapy

Jiang Yu, Yingli Wang, Shuang Zhou, Jinbo Li et al.

https://doi.org/10.1016/j.apsb.2020.04.011

A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy

Xinyu Hou, Chenting Shou, Muye He, Jiajun Xu et al.

https://doi.org/10.1016/j.apsb.2020.04.010

Inhibition of post-trabeculectomy fibrosis via topically instilled antisense oligonucleotide complexes co-loaded with fluorouracil

Kuan Jiang, Junyi Chen, Lingyu Tai, Chang Liu et al.

https://doi.org/10.1016/j.apsb.2020.03.002

Self-assembled natural phytochemicals for synergistically antibacterial application from the enlightenment of traditional Chinese medicine combination

Xuehao Tian, Penglong Wang, Tong Li, Xuemei Huang et al.

https://doi.org/10.1016/j.apsb.2019.12.014
-end-
For more information please visit https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/

Editorial Board: https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/editorial-board

APSB is available on ScienceDirect (https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b).

Submissions to APSB may be made using Editorial Manager® (https://www.editorialmanager.com/apsb/default.aspx).

CiteScore: 10.5

Impact Factor: 7.097

5-Year Impact Factor: 7.865

Source Normalized Impact per Paper (SNIP): 2.210

SCImago Journal Rank (SJR): 1.792ISSN 2211-3835

Compuscript Ltd

Related Mechanism Articles from Brightsurf:

Parkinson's dyskinesia mechanism explained
The mechanism underlying Parkinson's dyskinesia has been unknown, until now.

A cellular mechanism protecting against cancer
Susanne Hellmuth and Olaf Stemmann from the University of Bayreuth have discovered a natural protective mechanism that leads to the programmed death of potentially diseased cells.

New repair mechanism for DNA breaks
Researchers from the University of Seville and the Andalusian Centre of Molecular Biology and Regenerative Medicine (CABIMER) have identified new factors that are necessary for the repair of these breaks.

Antibiotics with novel mechanism of action discovered
Many life-threatening bacteria are becoming increasingly resistant to existing antibiotics.

New protein-sensing mechanism discovered
In a stunning discovery, molecular biologists from the University of Konstanz and ETH Zurich have been able to demonstrate that the nascent polypeptide-associated complex (NAC) senses newly synthesized proteins upon birth inside the ribosomal tunnel.

New deactivation mechanism for switch proteins detected
A new mechanism for the deactivation of switch proteins has been identified by researchers from Ruhr-Universit├Ąt Bochum, headed by Professor Klaus Gerwert and Dr.

A new mechanism for accessing damaged DNA
UV light damages the DNA of skin cells, which can lead to cancer.

New mechanism of bone growth discovered
In a paper published in Nature, researchers at Karolinska Institutet report that bone growth in mice takes place in accordance with the same principles as when new cells are constantly produced in blood, skin and other tissue.

An elegant mechanism
Researchers discovered a connection between metabolite and protein transport in the powerhouse of the cell.

A new mechanism in the control of inflammation
Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have discovered a new inflammation control mechanism that shows how the damage caused by the immune response can be controlled.

Read More: Mechanism News and Mechanism Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.